# EDGAR Filing Document

**Accession Number:** 0001852193
**File Stem:** 0001127602-23-006949
**Filing Date:** 2023-2
**Character Count:** 12471
**Document Hash:** f082ac1e97d1c06cf02855639d1ca4a5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-006949.hdr.sgml**: 20230223

**ACCESSION NUMBER**: 0001127602-23-006949

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230220

**FILED AS OF DATE**: 20230223

**DATE AS OF CHANGE**: 20230223

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Keshavan Santhosh
- **CENTRAL INDEX KEY:** 0001852193

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35897
- **FILM NUMBER:** 23662173

**MAIL ADDRESS:**
- **STREET 1:** 230 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10169
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Voya Financial, Inc.
- **CENTRAL INDEX KEY:** 0001535929
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **IRS NUMBER:** 521222820
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 230 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10169
- **BUSINESS PHONE:** 212-309-8200

**MAIL ADDRESS:**
- **STREET 1:** 230 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10169

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ING U.S., Inc.
- **DATE OF NAME CHANGE:** 20120709

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ING America Insurance Holdings, Inc.
- **DATE OF NAME CHANGE:** 20111130

## Ex-24

```

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes
and appoints each of My Chi To and Julie Watson of Voya Financial,
Inc.(the ?Company?), or any of them signing singly, and with full power
of substitution, the undersigned's true and lawful attorney-in-fact to:

(1)	prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and
Exchange Commission (the "SEC") a Form ID, including amendments
thereto, and any other documents necessary or appropriate to obtain
codes and passwords enabling the undersigned to make electronic
filings with the SEC of reports required by Section 16(a) of the
Securities Exchange Act of 1934 or any rule or regulation of the
SEC;

(2) 	execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of the Company,
Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder;

(3) 	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4, or 5, complete and execute any amendment
or amendments thereto, and timely file such form with the SEC and
any stock exchange or similar authority; and

(4) 	take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents executed
by such attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do
or cause to be done by virtue of this Power of Attorney and the rights
and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the
request of the undersigned, are not assuming, nor is the Company
assuming any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with
respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 1st day of February, 2023.

/s/ Santhosh Keshavan
Santhosh Keshavan

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Keshavan Santhosh<br><sub>(Last) (First) (Middle)</sub><br>230 PARK AVENUE<br><sub>(Street)</sub><br>NEW YORK, NY 10169<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Voya Financial, Inc. [ VOYA ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-02-20 | 2023-02-21 | M |  | 2874 | A | 0<sup>(1)</sup> | 20038 | D |  |
| Common Stock | 2023-02-20 | 2023-02-21 | F |  | 1332 | D | $74.44 | 18706 | D |  |
| Common Stock | 2023-02-20 | 2023-02-21 | M |  | 1239 | A | 0<sup>(1)</sup> | 19945 | D |  |
| Common Stock | 2023-02-20 | 2023-02-21 | F |  | 575 | D | $74.44 | 19370 | D |  |
| Common Stock | 2023-02-21 |  | M |  | 2531 | A | 0<sup>(1)</sup> | 21901 | D |  |
| Common Stock | 2023-02-21 |  | F |  | 1173 | D | $74.44 | 20728 | D |  |
| Common Stock | 2023-02-22 |  | M |  | 2140 | A | 0<sup>(1)</sup> | 22868 | D |  |
| Common Stock | 2023-02-22 |  | F |  | 992 | D | $73.34 | 21876 | D |  |
| Common Stock | 2023-02-22 |  | S |  | 3564<sup>(2)</sup> | D | 74.056<sup>(3)</sup> | 18312 | D |  |
| Common Stock | 2023-02-23 |  | S |  | 1148<sup>(2)</sup> | D | $73.47 | 17164 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Performance Stock Unit | <sup>(4)</sup> | 2023-02-20 | 2023-02-21 | M |  |  | 2874 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 2874 | $0 | 29985 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2023-02-20 | 2023-02-21 | M |  |  | 1239 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 1239 | $0 | 16521 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2023-02-21 |  | M |  |  | 2531 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 2531 | $0 | 13990 | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2023-02-22 |  | M |  |  | 2140 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 2140 | $0 | 11850 | D |  |
| Performance Stock Unit | <sup>(6)</sup> | 2023-02-22 |  | A |  | 13495 |  | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 13495 | $0 | 43480 | D |  |
| Restricted Stock Units | <sup>(6)</sup> | 2023-02-22 |  | A |  | 11044 |  | <sup>(8)</sup> | <sup>(8)</sup> | Common Stock | 11044 | $0 | 22894 | D |  |
| Performance-Based Stock Options | <sup>(9)</sup> |  |  |  |  |  |  | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 35587 |  | 35587 | D |  |

---

### Footnotes:

(1) Delivery of shares of the company's common stock was made to the reporting person without the payment of ay consideration in connection with the vesting of the underlying restricted stock units and performance stock units that were awarded as compensation.

(2) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022.

(3) This transaction was executed in multiple trades at prices ranging from $73.65 to $74.48.  The price reported represents the weighted average sale price of these trades.  The reporting person hereby undertakes to provide upon request to the SEC staff, the company, or a security holder of the company, full information regarding the shares sold at each seperate price.

(4) The performance stock units were awarded as compensation and convert to common stock based on the achievement of certain performance factors.

(5) The restricted stock units were awarded as compensation and converted to common stock based on the achievement of certain performance factors.

(6) The stock units will vest based on their respective award agreements.

(7) The number of shares of common stock that will be delivered for each performance stock unit depends on the achievement of certain performance factors.  Depending on actual performance, the number of shares of common stock delivered upon the vesting date (February 17, 2026) can range from 0% to 150% of the number presented above.

(8) 1/3 of the restricted stock units will vest on February 20, 2024, 1/3 on February 18, 2025 and 1/3 on February 17, 2026.

(9) The options vest based on the conditions set forth in their respective agreements.

**Remarks:**
Executive Vice President, Chief Information Officer | Exhibit List:  Exhibit 24 - Power of Attorney

**Signature:** /s/ My Chi To, Attorney-in-Fact  
**Date:** 2023-02-23

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**